PARSIPPANY, N.J., Dec. 11, 2012 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare today announced the launch of Quit.com, a total quit-smoking online resource to help smokers quit their cigarette addictions and stay smoke-free. Every smoker is different; therefore every smoker’s approach to quitting may need to be different. Quit.com houses personalized tools in a central, online location to help smokers navigate quitting smoking, no matter where they may be in their quit journey.
To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/59000-glaxosmithkline-consumer-healthcare-launches-quit-com-helps-smokers-quit
(Photo: http://photos.prnewswire.com/prnh/20121211/MM20744)
The website is built in four levels with specific tools depending on where smokers are in the quitting process. Quit.com has information for those who are preparing to quit, ready to quit, currently quitting or post-quit and looking for resources to remain a nonsmoker.
GSK Consumer Healthcare is committed to empowering and encouraging current smokers to kick the habit. The company built this personalized quitting resource based on the knowledge it has gained over the last 15 years in helping more than 9 million people quit smoking.
Each year, 15 million smokers try to quit smoking cigarettes, but only 5 percent actually succeed when they use no support or go cold turkey. Quit.com also offers information, tools and resources to help smokers through both the mental and physical aspects of quitting smoking.
“Quitting smoking is tough and requires focus and effort, but that’s only half the equation. Part of the addiction is behavioral a learned habit over time but the other part is neurobiology a chemical dependency to nicotine,” explains Saul Shiffman, Ph.D., an addiction and dependence expert and a world-renowned researcher in behavior change and relapse at the University of Pittsburgh and paid-consultant to GlaxoSmithKline Consumer Healthcare. “Using a combination of behavioral resources, education and quit smoking medicines can improve chances of success!”
Quit.com offers tools to help battle the mental aspects, such as picking your quit date, identifying your triggers and zeroing in on your inspiration to stay smoke-free, as well as resources to help fight the physical addiction, such as a quit guide to find the right nicotine replacement to help provide relief from cravings and product information.
When used as directed, using nicotine replacements in the form of gums, lozenges or patches can double a smoker’s chances of quitting. Nicotine replacement therapy (NRT) is designed to help relieve the cravings and withdrawal symptoms associated with quitting smoking by providing safe, controlled doses of nicotine. The controlled doses help calm cravings and irritability so smokers can focus on the psychological aspects of their habit.
NRT is a safe and effective approach to quitting smoking and is far safer than smoking cigarettes. NRT is more effective than quitting cold turkey, and it is available over the counter. As with any medication, you should follow the instructions on the package and talk to your doctor if you have questions or concerns.
For more information, please visit www.Quit.com.
About Quit.com
Quit.com is a total quit-smoking online resource to help smokers quit their cigarette addictions and stay smoke-free. The website offers information, tools and resources to help smokers through both the mental and physical aspects of quitting smoking. Quit.com houses personalized tools in a central, online location to help smokers navigate quitting smoking, no matter where they may be in their quit journey.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world’s largest over-the-counter consumer healthcare products companies. Its well-known brands include Nicorette® and NicoDerm® CQ, the leading smoking cessation products; alli, the only FDA-OTC weight loss aid; as well as medicine cabinet staples, Aquafresh®, Sensodyne®, Tums® and Breathe Right®, all of which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.
About GlaxoSmithKline
GlaxoSmithKline one of the world’s leading research-based pharmaceutical and healthcare companies is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.
Media Relations: | ||||
GSK Consumer Healthcare | Deborah Bolding | (973) 889-2344 | ||
GolinHarris | Catherine Bocke | (312) 729-4483 | ||
SOURCE GlaxoSmithKline Consumer Healthcare
